Modulation of apoptotic pathways triggered by cytotoxic agents

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Anticancer drugs induce tumor cell death primarily through apoptosis.
• Key pathways involve caspase activation, mitochondrial cytochrome c release, and death receptor signaling.
• The Bcl-2 protein family critically regulates apoptosis sensitivity at the mitochondrial level.

Purpose of the Study:

• To elucidate the molecular mechanisms by which anticancer drugs induce apoptosis.
• To explore how anticancer drugs modulate cell death pathways, including death receptors and Bcl-2 family proteins.
• To identify novel strategies for improving anticancer drug efficacy based on identified pathways.

Main Methods:

• Analysis of caspase activation pathways.
• Investigation of mitochondrial outer membrane permeabilization.
• Assessment of death receptor and ligand interactions.
• Modulation of Bcl-2 family protein expression and localization.
• Examination of lipid- and kinase-dependent signaling pathways.
• Identification of protective pathways such as NF-kappa B activation.

Main Results:

• Anticancer drugs activate caspases via cytochrome c release from mitochondria.
• Drug-induced apoptosis can be amplified by upregulating death receptors.
• Bcl-2 family proteins are modulated by chemotherapeutic drugs at transcriptional, post-translational, and localization levels.
• Signaling pathways involving lipids and kinases influence the response to anticancer drugs.
• Protective mechanisms like NF-kappa B activation and heat shock proteins counteract drug-induced death.

Conclusions:

• Anticancer drugs induce apoptosis through complex molecular pathways involving mitochondria, death receptors, and signaling cascades.
• Modulation of Bcl-2 family proteins and signaling pathways represents a key mechanism of action for chemotherapeutic agents.
• Targeting these identified cell death and survival pathways holds promise for developing more effective anticancer therapies.